Effect of High Frequency Electrical Currents in Healthy Subjects.

February 17, 2020 updated by: University of Castilla-La Mancha

Application of High Frequency Electrical Currents: Effects on Mechanical Threshold, Tactile Threshold and Evoked Potentials in Healthy Subjects.

The purpose of this study is to determine whether the transcutaneous application of unmodulated high frequency alternating currents could produce a quickly conduction block of peripheral nerve.

Study Overview

Status

Completed

Detailed Description

In the last years several animal experimental studies have evidenced that high frequency unmodulated currents about 5 KHz can cause a peripheral nerve block. However electric currents with these high frequencies that are usually used for the treatment of pain in humans are interrupted or modulated (i.e. interferential currents).

It has show that the diameter of the nerve it is related with the frequency to produce the conduction block. For this reason we decided to applied 30KHz to observe the effects on pain in patients with whiplash and to compare versus sham stimulation.

Only one study has applied 5KHz on experimental pain and they have demonstrated changes in somatosensory thresholds.

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Toledo, Spain, 45004
        • Diego Serrano-Muñoz

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy volunteers

Exclusion Criteria:

  • Neuromuscular disease.
  • Epilepsy.
  • Trauma, surgery or pain affecting the upper limb, shoulder girdle or cervical area.
  • Osteosynthesis material in the upper limb.
  • Diabetes.
  • Cancer.
  • Cardiovascular disease.
  • Pacemaker or other implanted electrical device.
  • Take any drug (NSAIDs, corticosteroids, antidepressants, analgesics, antiepileptics, ...) during the study and in the previous 7 days.
  • Presence of tattoos or other external agent introduced into the treatment or assessment area.
  • Pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High-Frequency
Transcutaneous application of high frequency electrical current over the arm for a 30 minutes session. The intensity of the current will increase until participants report a "strong but comfortable" sensation, just below motor threshold.
high-Frequency electrical stimulation over superficial radial nerve through the electrotherapy device Myomed 932. (Enraf-Nonius, Delft, Netherlands)
Sham Comparator: Sham Stimulation
Electrodes are placed over the arm for a 30 minutes in the same manner as experimental group but will be applied a sham electrical stimulation increasing the current intensity of an unconnected channel.
Sham transcutaneous electrical stimulation over superficial radial nerve through the electrotherapy device Myomed 932. (Enraf-Nonius, Delft, Netherlands)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baseline Mechanical Pain Threshold
Time Frame: baseline at 0 min
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton
baseline at 0 min
Baseline Tactile Threshold
Time Frame: baseline at 0 min
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton
baseline at 0 min
Baseline Muscle Strength
Time Frame: Baseline at 0 min
The muscle strength will be measured with a dynamometer and will be expressed in Newton
Baseline at 0 min
Mechanical Pain Threshold after treatment at 30 min
Time Frame: Immediately after treatment at 30 min
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton
Immediately after treatment at 30 min
Tactile Threshold after treatment at 30 min
Time Frame: Immediately after treatment at 30 min
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton
Immediately after treatment at 30 min
Muscle Strength after treatment at 30 min
Time Frame: Immediately after treatment at 30 min
The muscle strength will be measured with a dynamometer and will be expressed in Newton
Immediately after treatment at 30 min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Mechanical Pain Threshold
Time Frame: baseline at 0 min, immediately after treatment at 30 min
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton
baseline at 0 min, immediately after treatment at 30 min
Change from baseline in TactileThreshold
Time Frame: baseline at 0 min, immediately after treatment at 30 min
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton
baseline at 0 min, immediately after treatment at 30 min
Change from baseline in Muscle strength
Time Frame: baseline at 0 min, immediately after treatment at 30 min
The muscle strength will be measured with a dynamometer and will be expressed in Newton
baseline at 0 min, immediately after treatment at 30 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Diego Serrano-Muñoz, MsC, Hospital Nacional de Parapléjicos, Toledo

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Actual)

September 30, 2017

Study Completion (Actual)

December 20, 2017

Study Registration Dates

First Submitted

July 15, 2016

First Submitted That Met QC Criteria

July 15, 2016

First Posted (Estimate)

July 19, 2016

Study Record Updates

Last Update Posted (Actual)

February 19, 2020

Last Update Submitted That Met QC Criteria

February 17, 2020

Last Verified

April 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • ddsm18

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on High Frequency Current

Clinical Trials on High-Frequency

Subscribe